mounjaro glp-1 Stroke: GLP-1s Like Ozempic, May Reduce Cardiovascular Risks Mounjaro Medicine: What This Search
Description
Harms and Benefits of Sodium-Glucose Co-Transporter 2 Inhibitors
Posted on Lancet September 12, 2022
NylanderMFrssingSClausenHKistorpCFaberJSkoubyS
Melissa Sleight, RDN Medical Reviewer Judy Mouchawar, MD, MSPH Medical Reviewer Judy Mouchawar, MD, MSPH, is a medical director in clinical affairs
AOM, anti-obesity medication
In fact, the goal of GLP-1 use is to focus on physical health, mental health and well-being, rather than body weight alone (Mozafarriun et al 2025)
